[Clinical experience with atracurium--a continuous infusion technic]. 1987

P J Fourie, and M Versace, and P A Lambert, and A J Lessing
Departement Anestesiologie, Universiteit van Pretoria.

A continuous infusion technique for atracurium was investigated. It provided a stable neuromuscular block, with a mean infusion rate of 0.008 mg/kg/min after an initial bolus of 0.5 mg/kg. A wide individual response was found and an arbitrary infusion rate based on mass alone is therefore not possible. The above rate is thus a starting point and should be adjusted according to individual requirements, preferably by using a peripheral nerve stimulator. The technique obviates the need for repeated increments of atracurium during lengthy surgical procedures.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D009407 Nerve Block Interruption of NEURAL CONDUCTION in peripheral nerves or nerve trunks by the injection of a local anesthetic agent (e.g., LIDOCAINE; PHENOL; BOTULINUM TOXINS) to manage or treat pain. Chemical Neurolysis,Chemodenervation,Nerve Blockade,Block, Nerve,Blockade, Nerve,Blockades, Nerve,Blocks, Nerve,Chemical Neurolyses,Chemodenervations,Nerve Blockades,Nerve Blocks,Neurolyses, Chemical,Neurolysis, Chemical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001279 Atracurium A non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents. Atracurium Besylate,Atracurium Dibesylate,33 A 74,Atracurium Besilate,BW-33A,Relatrac,Tracrium,A 74, 33,BW 33A,BW33A,Besilate, Atracurium
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

P J Fourie, and M Versace, and P A Lambert, and A J Lessing
November 1990, British journal of anaesthesia,
P J Fourie, and M Versace, and P A Lambert, and A J Lessing
February 1986, Anesthesiology,
P J Fourie, and M Versace, and P A Lambert, and A J Lessing
September 1989, Minerva anestesiologica,
P J Fourie, and M Versace, and P A Lambert, and A J Lessing
January 1986, British journal of anaesthesia,
P J Fourie, and M Versace, and P A Lambert, and A J Lessing
January 1988, Polski tygodnik lekarski (Warsaw, Poland : 1960),
P J Fourie, and M Versace, and P A Lambert, and A J Lessing
September 1990, Minerva anestesiologica,
P J Fourie, and M Versace, and P A Lambert, and A J Lessing
October 1988, Anaesthesia,
P J Fourie, and M Versace, and P A Lambert, and A J Lessing
August 1989, Anaesthesia and intensive care,
P J Fourie, and M Versace, and P A Lambert, and A J Lessing
March 1995, Minerva anestesiologica,
P J Fourie, and M Versace, and P A Lambert, and A J Lessing
June 1995, Critical care medicine,
Copied contents to your clipboard!